As the Australian market faces a challenging week with futures down and global tariff tensions looming, investors are keenly observing potential opportunities. Despite its somewhat outdated name, the concept of penny stocks remains relevant for those interested in smaller or newer companies that might offer substantial value. By focusing on firms with solid financial foundations and growth potential, investors can uncover hidden gems within this sector. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.40 A$114.64M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.03 A$95.76M ★★★★★★ GTN (ASX:GTN) A$0.57 A$108.68M ★★★★★★ IVE Group (ASX:IGL) A$2.95 A$454.84M ★★★★★☆ West African Resources (ASX:WAF) A$2.35 A$2.68B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.775 A$469.33M ★★★★★★ Regal Partners (ASX:RPL) A$2.92 A$981.78M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.37 A$134.79M ★★★★★★ CTI Logistics (ASX:CLX) A$1.86 A$149.81M ★★★★☆☆ Click here to see the full list of 460 stocks from our ASX Penny Stocks screener. Here's a peek at a few of the choices from the screener. CleanSpace Holdings Simply Wall St Financial Health Rating: ★★★★★☆ Overview: CleanSpace Holdings Limited designs, manufactures, and sells respiratory protection products and services for healthcare and industrial markets globally, with a market cap of A$59.48 million. Operations: The company generates revenue of A$17.61 million from its respiratory products segment. Market Cap: A$59.48M CleanSpace Holdings, with a market cap of A$59.48 million, is navigating the challenges of being unprofitable while generating A$17.61 million in revenue from its respiratory products. Despite its negative return on equity and increasing losses over the past five years, it has managed to reduce its debt-to-equity ratio significantly from 51.9% to 14.8%. The company's short-term assets comfortably cover both short- and long-term liabilities, indicating financial stability in the near term. However, the management team lacks extensive experience with an average tenure of 1.9 years, which could impact strategic execution moving forward. Click to explore a detailed breakdown of our findings in CleanSpace Holdings' financial health report. Gain insights into CleanSpace Holdings' future direction by reviewing our growth report.ASX:CSX Financial Position Analysis as at Aug 2025 Sandon Capital Investments Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sandon Capital Investments Limited is a publicly owned investment manager with a market capitalization of A$129.27 million. Story Continues Operations: The company's revenue is derived entirely from Investing Activities, totaling A$23.02 million. Market Cap: A$129.27M Sandon Capital Investments, with a market cap of A$129.27 million, shows financial resilience as its short-term assets (A$167.4M) exceed both short- and long-term liabilities. The company's net profit margins have improved to 70.7%, although it faced negative earnings growth over the past year, contrasting with the industry average growth of 23.4%. Its debt is not well covered by operating cash flow but remains manageable due to more cash than total debt and strong interest coverage by EBIT (9.1x). Despite a low return on equity at 12.6%, its price-to-earnings ratio suggests it may be undervalued compared to the broader Australian market. Dive into the specifics of Sandon Capital Investments here with our thorough balance sheet health report. Explore historical data to track Sandon Capital Investments' performance over time in our past results report.ASX:SNC Financial Position Analysis as at Aug 2025 Shaver Shop Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Shaver Shop Group Limited operates as a retailer of personal care and grooming products in Australia and New Zealand, with a market cap of A$193.90 million. Operations: The company's revenue is primarily generated through retail store sales of specialist personal grooming products, amounting to A$218.14 million. Market Cap: A$193.9M Shaver Shop Group Limited, with a market cap of A$193.90 million, operates debt-free and demonstrates financial stability as its short-term assets (A$62.1M) exceed both short- and long-term liabilities. The company has experienced negative earnings growth over the past year (-6.1%), yet forecasts suggest a 7.96% annual growth in earnings moving forward. Despite a decline in net profit margins from 7.1% to 6.7%, Shaver Shop's seasoned management team and high-quality past earnings contribute to its resilience in the market, trading at 54.3% below estimated fair value without significant shareholder dilution recently observed. Click here to discover the nuances of Shaver Shop Group with our detailed analytical financial health report. Evaluate Shaver Shop Group's prospects by accessing our earnings growth report.ASX:SSG Revenue & Expenses Breakdown as at Aug 2025 Summing It All Up Click here to access our complete index of 460 ASX Penny Stocks. Ready For A Different Approach? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CSX ASX:SNC and ASX:SSG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Penny Stocks To Watch With Market Caps Under A$200M
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...